V

Vaxcell Bio Therapeutics
KOSDAQ:323990

Watchlist Manager
Vaxcell Bio Therapeutics
KOSDAQ:323990
Watchlist
Price: 9 990 KRW -0.99% Market Closed
Market Cap: 232.4B KRW

Intrinsic Value

The intrinsic value of one Vaxcell Bio Therapeutics stock under the Base Case scenario is hidden KRW. Compared to the current market price of 9 990 KRW, Vaxcell Bio Therapeutics is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Vaxcell Bio Therapeutics Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Vaxcell Bio Therapeutics

Intrinsic Value History
Dive into the past to invest in the future

Vaxcell Bio Therapeutics looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether Vaxcell Bio Therapeutics usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Vaxcell Bio Therapeutics?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Vaxcell Bio Therapeutics valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Vaxcell Bio Therapeutics.

Explain Valuation
Compare Vaxcell Bio Therapeutics to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Contacts
Loading...
How do you feel about Vaxcell Bio Therapeutics?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Vaxcell Bio Therapeutics

Current Assets 37.1B
Cash & Short-Term Investments 32.2B
Receivables 3.5B
Other Current Assets 1.4B
Non-Current Assets 35.7B
Long-Term Investments 14.9B
PP&E 6.3B
Intangibles 7.7B
Other Non-Current Assets 6.7B
Current Liabilities 2.9B
Accounts Payable 556.4m
Accrued Liabilities 303.3m
Other Current Liabilities 2.1B
Non-Current Liabilities 2.1B
Long-Term Debt 1.2B
Other Non-Current Liabilities 862.4m
Efficiency

Free Cash Flow Analysis
Vaxcell Bio Therapeutics

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Vaxcell Bio Therapeutics

Revenue
5.5B KRW
Cost of Revenue
-4.6B KRW
Gross Profit
955.3m KRW
Operating Expenses
-17.2B KRW
Operating Income
-16.3B KRW
Other Expenses
4.1B KRW
Net Income
-12.2B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Vaxcell Bio Therapeutics's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Healthy Gross Margin
Sustainable 3Y Average Gross Margin
hidden
Profitability
Score

Vaxcell Bio Therapeutics's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Vaxcell Bio Therapeutics's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
hidden
Solvency
Score

Vaxcell Bio Therapeutics's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Vaxcell Bio Therapeutics

There are no price targets for Vaxcell Bio Therapeutics.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Vaxcell Bio Therapeutics
does not pay dividends
Shareholder Yield

Current shareholder yield for Vaxcell Bio Therapeutics is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Vaxcell Bio Therapeutics stock?

The intrinsic value of one Vaxcell Bio Therapeutics stock under the Base Case scenario is hidden KRW.

Is Vaxcell Bio Therapeutics stock undervalued or overvalued?

Compared to the current market price of 9 990 KRW, Vaxcell Bio Therapeutics is hidden .

Back to Top